Drug Prices
Last week, I shared a few areas where we can advance health in America this year, even in a divided Congress. Number one on that list: reining in the skyrocketing costs of prescription drugs.
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and staffing investments and identify alternative therapies.
Drug spending is rising dramatically on top of historic growth. High drug prices create real challenges for hospitals and the patients they treat.
The American Hospital Association (AHA), the Federation of American Hospitals (FAH), and the American Society of Health-System Pharmacists (ASHP) released a new report finding that continued rising drug prices, as well as shortages for many critical medications, are impacting patient care and…
We’re 11 days into 2019 … we’ve returned to a divided government …and the partial government shutdown continues.
Also in this weekly roundup of health news: AHA president and CEO Rick Pollack speaks to HealthLeaders about the association’s year ahead; digital health startups growing presence at this year’s Consumer Electronics Show; how consumers are and aren’t using popular health apps; and some Medicaid…
As Congress prioritizes action to lower drug prices, the Campaign for Sustainable Rx Pricing yesterday announced a website to help lawmakers and their staff better understand the crisis and bipartisan, market-based solutions.
AHA commends the Centers for Medicare & Medicaid Services' willingness to address excessive growth in drug prices, but urges CMS to consider narrowing the scope of the program.
AHA comments on the Centers for Medicare & Medicaid Services’ advance notice of proposed rulemaking on the International Pricing Index model for Medicare Part B drugs.